Risk Of Developing Liver Cancer After HCV Treatment

Monday, November 8, 2010

2010 AASLD Conference News At Medscape


Conference News
AASLD Short-Course Telaprevir Equal to Full-Course in Some Patients With HCV
Medscape Medical News, November 8, 2010
AASLD Telbivudine Prevents HBV Perinatal Transmission
Medscape Medical News, November 8, 2010
AASLD Abnormal Liver Histology in HIV-Positive Patients Is Cause for Concern
Medscape Medical News, November 8, 2010
AASLD Extended Follow-Up of HALT-C Study Shows Some Benefit of Interferon
Medscape Medical News, November 7, 2010
AASLD Drug Combination Demonstrates Proof of Concept in Controlling HCV
Medscape Medical News, November 4, 2010
AASLD More Evidence Coffee May Slow Liver Disease
Reuters Health Information, November 4, 2010
AASLD Liver Graft Quality Significantly Poorer With Female Vs Male Donors
Reuters Health Information, November 4, 2010
AASLD Metformin, Vitamin E Do Not Significantly Improve NAFLD in Children
Medscape Medical News, November 4, 2010
AASLD Black Patients Fare Well on New Hepatitis C Drug Telaprevir
Reuters Health Information, November 2, 2010
AASLD Twelve-Week Interim Analysis of HCV Protease Inhibitor Danoprevir is Positive
Medscape Medical News, November 1, 2010

No comments:

Post a Comment